What is quantum computing? That’s a question still being asked by much of the world’s C-suite. But here at CC our multidisciplinary teams of physicists, engineers and designers are already helping to plot a credible pathway for a future powered by quantum technologies
What can quantum computing and quantum technology do for the pharma and life sciences industry? Elizabeth Thomas has conferred with Cambridge Consultants’ quantum experts and shares her insights into how organisations can start implementing an action plan.
Not everyone knows how to embark on the road to a new market breakthrough – or has the confidence to overcome natural hesitancy. At CC, we believe in the design thinking approach known as DVF (Desirability, Viability, Feasibility).
The world of DNA testing is changing fast and the race is on to provide cheap, quick genetic diagnoses for patients. Symon Cotton, Head of Life Sciences takes a look at the opportunities on offer for companies working in this dynamic field.
Global pharma is hitting a major fork in the road, and one way leads to failure. For me, it’s vital that the industry comes together to grasp the once-in-a-generation opportunity that emergent technology is offering.
Founders of early-stage start-ups are passionate, driven and optimistic. So, as they embark on the mission to sell their vision, they should accentuate the positive and keep negative thoughts of risk to the back of their mind, right? Wrong.